Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OVHIPEC-I: Phase III trial of secondary debulking surgery with or without hyperthermic intraperitoneal chemotherapy in stage III ovarian carcinoma
2006-003466-34Phase 3Active
- Sponsor
- Netherlands Cancer Institute
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of cisplatin in ovarian cancer, primary peritoneal cancer (PPC) and fallopian tube cancer (PFTC) (2 arms), sponsored by Netherlands Cancer Institute. Primary endpoint: Progression-free survival. Started Oct 2006; status: active.
02
Drugs
cisplatin
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on 2006-003466-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003466-34.